Conduent (CNDT) Competitors $2.12 +0.08 (+3.92%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNDT vs. GDRX, ASTH, GB, VVX, PHR, STGW, LZ, UPBD, IBTA, and APLDShould you be buying Conduent stock or one of its competitors? The main competitors of Conduent include GoodRx (GDRX), Astrana Health (ASTH), Global Blue Group (GB), V2X (VVX), Phreesia (PHR), Stagwell (STGW), LegalZoom.com (LZ), Upbound Group (UPBD), Ibotta (IBTA), and Applied Digital (APLD). These companies are all part of the "business services" industry. Conduent vs. GoodRx Astrana Health Global Blue Group V2X Phreesia Stagwell LegalZoom.com Upbound Group Ibotta Applied Digital Conduent (NASDAQ:CNDT) and GoodRx (NASDAQ:GDRX) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Is CNDT or GDRX more profitable? Conduent has a net margin of 12.69% compared to GoodRx's net margin of -2.05%. GoodRx's return on equity of 5.35% beat Conduent's return on equity.Company Net Margins Return on Equity Return on Assets Conduent12.69% -11.39% -3.21% GoodRx -2.05%5.35%2.51% Do institutionals and insiders believe in CNDT or GDRX? 77.3% of Conduent shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 1.8% of Conduent shares are held by company insiders. Comparatively, 4.2% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer CNDT or GDRX? In the previous week, GoodRx had 3 more articles in the media than Conduent. MarketBeat recorded 10 mentions for GoodRx and 7 mentions for Conduent. Conduent's average media sentiment score of 1.46 beat GoodRx's score of 0.63 indicating that Conduent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conduent 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in CNDT or GDRX? GoodRx received 58 more outperform votes than Conduent when rated by MarketBeat users. Likewise, 39.67% of users gave GoodRx an outperform vote while only 30.00% of users gave Conduent an outperform vote. CompanyUnderperformOutperformConduentOutperform Votes1530.00% Underperform Votes3570.00% GoodRxOutperform Votes7339.67% Underperform Votes11160.33% Do analysts recommend CNDT or GDRX? GoodRx has a consensus target price of $7.93, suggesting a potential upside of 76.66%. Given GoodRx's stronger consensus rating and higher probable upside, analysts clearly believe GoodRx is more favorable than Conduent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conduent 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00GoodRx 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73 Which has higher valuation & earnings, CNDT or GDRX? Conduent has higher revenue and earnings than GoodRx. Conduent is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConduent$3.36B0.10$426M$2.160.98GoodRx$792.32M2.17-$8.87M$0.0589.80 Which has more risk & volatility, CNDT or GDRX? Conduent has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. SummaryGoodRx beats Conduent on 11 of the 19 factors compared between the two stocks. Remove Ads Get Conduent News Delivered to You Automatically Sign up to receive the latest news and ratings for CNDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNDT vs. The Competition Export to ExcelMetricConduentBusiness services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$343.08M$19.39B$7.02B$7.58BDividend YieldN/A2.93%2.71%4.33%P/E Ratio0.9832.2129.8217.78Price / Sales0.107.24148.3094.51Price / Cash5.1732.3031.6134.64Price / Book0.414.884.553.99Net Income$426M$671.24M$196.25M$247.24M7 Day Performance-4.93%5.53%5.30%8.29%1 Month Performance-32.27%-7.99%-6.14%-5.37%1 Year Performance-33.12%13.49%3.06%-0.24% Conduent Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNDTConduent2.4547 of 5 stars$2.12+3.9%N/A-33.8%$343.08M$3.36B0.9862,000News CoveragePositive NewsGDRXGoodRx3.1246 of 5 stars$4.02-2.5%$8.18+103.6%-34.3%$1.54B$792.32M-133.83950News CoverageASTHAstrana Health3.8022 of 5 stars$29.24-2.8%$53.29+82.3%-16.4%$1.47B$2.03B22.491,800Positive NewsGBGlobal Blue Group1.2349 of 5 stars$7.24-0.8%$6.00-17.1%+41.6%$1.45B$486.34M34.481,410High Trading VolumeVVXV2X3.6966 of 5 stars$45.32-0.3%$65.38+44.2%+12.5%$1.43B$4.32B161.888,100Analyst ForecastNews CoveragePHRPhreesia3.959 of 5 stars$24.04-1.1%$31.33+30.4%+0.9%$1.41B$419.81M-16.351,700Analyst ForecastSTGWStagwell2.1566 of 5 stars$5.06-5.1%$9.08+79.6%-5.5%$1.35B$2.84B252.8512,200LZLegalZoom.com2.5838 of 5 stars$7.45-5.0%$9.19+23.4%-44.1%$1.31B$681.88M57.271,220Short Interest ↑Positive NewsGap UpUPBDUpbound Group4.2385 of 5 stars$21.95-0.2%$37.00+68.6%-32.9%$1.26B$4.32B9.9312,700Positive NewsGap UpIBTAIbotta0.4305 of 5 stars$43.79-0.8%N/AN/A$1.22B$367.25M24.46N/AAnalyst ForecastShort Interest ↑APLDApplied Digital3.3201 of 5 stars$5.18+5.3%$12.11+133.8%+98.2%$1.15B$211.62M-2.99121News CoverageGap Down Remove Ads Related Companies and Tools Related Companies GoodRx Competitors Astrana Health Competitors Global Blue Group Competitors V2X Competitors Phreesia Competitors Stagwell Competitors LegalZoom.com Competitors Upbound Group Competitors Ibotta Competitors Applied Digital Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CNDT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduent Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNDT Stock Free CNDT Stock Alerts